Swap BIO at the Best Rate

BIO is the token of Bio Protocol, a funding and curation network for decentralized science that launches and supports biotech DAOs. Holders lock BIO to vote new BioDAOs into the network, gain access to their fundraises and seed liquidity for their tokens. Built by the team behind Molecule and VitaDAO, the token went live in January 2025 on Ethereum with a Binance Launchpool debut.

Swap
BIO
0.024401-0.97%
Live price chart is unavailable right now

Stats

Market cap
$54.9M
Fully diluted valuation (FDV)
$80.1M
Circulating supply
2.3B BIO
Total supply
3.3B BIO
Volume (24h)
$18.3K
Swaps (24h)
Contract address
0xcb15…5ffa

Data updated 2026-08-18

About BIO

BIO is a token traded on Ethereum. On 1inch, the swap aggregator compares supported routes across DEX liquidity to help improve a crypto swap involving BIO, while you keep full control of your funds in your own wallet.

BIO ranks #58 by 24-hour trading volume among the tokens tracked on 1inch, with $18.3K traded over the last day. It is a micro-cap asset, with a market capitalization of around $54.9M. Ethereum is the only network where the 1inch token catalog lists BIO.

BIO at a glance

Launched
3 January 2025, via Binance Launchpool
Issuer
Bio Protocol, built by the Molecule team
Token standard
ERC-20 on Ethereum; also deployed on Solana and Base
Supply
3,320,000,000 BIO at genesis; 56% to community programs
Governance
BIO holder votes curate BioDAOs and set incentives
Primary utility
Curation locking, launch access, liquidity, BioAgents

What is BIO?

BIO is the coordination token of Bio Protocol, which applies token networks to early-stage biotech funding. Research communities called BioDAOs, such as VitaDAO for longevity or HairDAO for hair loss, raise capital, fund experiments and hold the resulting intellectual property as on-chain assets, and Bio Protocol is the layer that curates, funds and supplies liquidity to them.

The token launched on 3 January 2025 on Ethereum, debuting as a Binance Launchpool project after farming opened in late December 2024, and was deployed to Solana that month over a Wormhole-powered bridge, with Base following for the protocol's launchpad.

How BIO works

Bio V1, live since late March 2025 on Solana and Base, runs BioDAO launches in three phases. In curation, holders lock BIO to vote a proposed BioDAO in, with the first cohort locking for 60 days. In funding, curators get access to the new DAO's token auction. In liquidity, locked BIO pairs with the new token in automated market maker pools.

The protocol keeps a stake in what it launches: its treasury takes an allocation of each BioDAO, collects launchpad fees and runs BioAgents, AI research assistants whose service fees flow back to the protocol, with fees recycled into liquidity or burns.

BIO supply and tokenomics

Genesis supply is 3.32 billion BIO. Community programs hold 56%, split across ecosystem incentives at 25%, a community auction at 20%, an airdrop at 6% and a Molecule ecosystem fund at 5%, while core contributors hold 21.2%, investors 13.6%, advisors 4.2% and Molecule 5%.

Roughly 39% of supply was circulating at launch per exchange research, with contributor and investor allocations locked at the token generation event and vesting afterward, so unlock flow continues for years after the January 2025 debut.

Who builds BIO

Bio Protocol comes from the team behind Molecule, the Berlin company that built IP-NFT legal and technical rails for tokenized research, and that co-created VitaDAO, the largest longevity DAO. Co-founder Paul Kohlhaas leads it, and YZi Labs, formerly Binance Labs, made the protocol its first decentralized-science investment in November 2024.

How BIO is governed

BIO holders vote on which BioDAOs join the network and on incentive programs, with locked or staked BIO carrying the weight. Through treasury holdings of BioDAO tokens, protocol governance also reaches into decisions across the network it has funded, a structure the team calls meta-governance.

What people use BIO for

BIO is designed so that using it means participating in the pipeline of new BioDAOs rather than only holding a governance right.

  • Lock BIO to curate BioDAO launches and earn discounted allocations.
  • Vote on ecosystem incentives and network membership.
  • Supply BIO-paired liquidity for BioDAO tokens.
  • Run or fund BioAgents, the protocol's AI research assistants.

BIO risks and considerations

BIO launched in 2025 and most of its supply was locked at the start, so contributor and investor vesting adds a steady flow of new supply for years. Its value case also depends on a pipeline of credible BioDAOs choosing to launch through the protocol.

The underlying assets are early-stage science: preclinical research fails often and takes years, tokenized intellectual property is a young legal construct, and the protocol spreads across Ethereum, Solana and Base, which adds bridge risk to the mix.

Trade professionally

Take BIO trading further with limit orders, live charts and route control in the 1inch Terminal — the pro trading surface of the 1inch dApp. You keep self-custody of your funds while getting deeper execution context for every trade.

Open Terminal

Questions? Answers.

Sources

Content reviewed July 25, 2026